黛力新对功能性消化不良疾病患者临床疗效和心理状态的影响.doc

黛力新对功能性消化不良疾病患者临床疗效和心理状态的影响
作者:

[摘要] 目的 探究黛力新對功能性消化不良疾病患者临床疗效和心理状态的影响。 方法 便利选取该院control group, % and %(χ2=, , P=, ); The anxiety and depression scores of the observation group were (±) points and (± )points respectively, which were significantly lower than those of the control group (±) points and (±) points, the difference was statistically significante (t=, , P<); The observation group's sleep quality score was (±) points, which was significantly better than the control group (±)points (t=, P<); In terms of quality of life, the total score of patients in the observation group was (±)points, which was significantly higher than that of the control group (±)points, the difference was statistically significant(P<). Conclusion The anxiety and depression of patients with functional dyspepsia have been significantly improved after treatment with Delixin (Flupentixol and melitracen tablets), which is of great significance to promote the physical recovery of patients and is worthy of clinical promotion and implementation. [Key words] Deanxit; Mosapride; Pantoprazole; Functional Dyspepsia; Clinical Efficacy; Psychological Status; Quality of Life
功能性胃肠病是临床胃肠疾病的统称,在成人中共包括6大类28种疾病,而功能性消化不良是最为常见的一种,该类疾病患者主要表现为便秘、腹泻、腹胀、腹痛、早饱等症状,其在治疗后具有较高的复发率,严重影响人们的身体健康和生活质量[1]。据医学文献记载,功能性消化不良属于上消化道功能紊乱疾病,发病机制较为复杂,与胃运动、胃酸、胃肠排空功能、心理状态、幽门螺杆菌感染等均存在一定联系,其中,心理因素是该疾病病情发展的重要影响因素,诸多调查显示,该疾病患者患病期间普遍存在焦虑、抑郁心理[2-3]。研究发现,黛力新对于功能性消化不良伴焦虑症患者具有较为理想的治疗效果[4]。该研究便利选择2017年1月—2018年12月期间该院收治的100例功能性消化道不良疾病患者分组治疗,并观察临床治疗效果,现报道如下。
1 资料与方法
一般资料
便利选取该院收治的功能性消化不良患者100例随机分为对照组和观察组,其中对照组患者50例,男22例,女28例;年龄18~75岁,平均年龄(±)岁;~,平均病程(±)年;体重46~72 kg,平均体重(±)kg;文化程度包括大学及以上19例,初高中29例,小学及以下2例。观察组患者50例,男19例,女31例;年龄19~71岁,平均年龄(±)岁;~,平均病程(±)年;体重44~70 kg,平均体重(±)kg;文化程度包括大学及以上18例